Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 2 4Phase 4 3Phase 2/3 2Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Neoplasms 1Lymphoma 1Leukemia 1Hematologic Diseases 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Water × Clear all
NCT02095951 2018-12-19

Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection

Children's Hospital of Michigan

Phase 4 Completed
30 enrolled 8 charts
LymphoidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphoma

NCT01653171 2018-04-10

PRUE

Pontificia Universidad Catolica de Chile

Phase 4 Completed
230 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02173964 2016-04-15

Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)

Seoul National University Hospital

Phase 4 Completed
58 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡